Aurinia Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +165.1% | +237.2% | +165.3% | +36.7% | +46.9% | -17.8% | -11.2% | -43.6% | +39.3% | -37.5% | -64.2% | +7.7% | +39.3% | -71.0% | +456.4% | +126.3% | -35.9% | +69.8% | +233.1% | -23.2% | +122.3% | +43.0% | +17.2% | -13.3% | +16.4% | +0.5% | +36.5% | |
| – | +421.5% | +312.1% | +177.8% | +25.3% | +46.3% | -18.4% | -10.4% | -49.6% | +49.5% | -38.4% | -75.1% | +21.7% | +26.4% | -94.7% | +371.4% | +1,502.0% | -50.7% | +150.5% | +323.1% | -24.2% | +137.2% | +33.1% | +22.4% | -13.8% | -4.0% | +5.1% | +10.2% | |
| – | – | +106.2% | +478.9% | -35.6% | +39.2% | -46.1% | +12.3% | -20.0% | +142.0% | -34.7% | -78.3% | +38.5% | -6.7% | -96.9% | +883.6% | +1,148.2% | -74.6% | +588.8% | +317.7% | -28.8% | +159.4% | -11.0% | -14.9% | -59.4% | -48.1% | +70.7% | -3.9% | |
| – | +258,057,400.0% | +356.9% | +183.8% | +21.9% | +54.1% | -20.3% | -9.2% | -51.4% | +46.4% | -34.7% | -78.3% | +38.5% | -6.7% | -96.9% | +883.6% | +1,697.7% | -51.8% | +151.7% | +337.5% | -27.4% | +143.2% | +30.2% | +17.0% | -16.5% | -10.0% | +2.3% | +11.0% | |
| – | -30.5% | +13.7% | +150.7% | +476.5% | -87.1% | +20.3% | +11.0% | +3.2% | +23.0% | -16.8% | +21.9% | -77.0% | +130.1% | -30.3% | -42.0% | -13.2% | -48.9% | +83.0% | +26.7% | +99.1% | +69.6% | -86.1% | +30,123.5% | -12.5% | +78.7% | +51.7% | +13.4% | |
| – | +160.8% | +64.6% | -2.2% | -5.5% | +8.7% | +7.4% | -55.5% | -4.5% | +682.6% | -94.0% | -100.0% | +0.0% | +19,490,500.0% | -100.0% | -30.6% | – | – | – | -10,900,100.0% | – | – | – | +38.8% | +28.1% | +60.4% | -1.2% | +16.5% | |
| – | – | – | +42.8% | +370.5% | +50.4% | -17.5% | -21.3% | -14.5% | -9.4% | -39.0% | -25.1% | -35.7% | -48.7% | -86.4% | -58.6% | +41.6% | -30.8% | -19.4% | +6.9% | +32.3% | +126.8% | +5,046.2% | +104.8% | -12.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +39.1% | +0.8% | +56.9% | +32.4% | +51.1% | +4.0% | +6.0% | +17.9% | +34.0% | -24.0% | -5.1% | -7.0% | +58.3% | -4.7% | +588.0% | -11.4% | -8.1% | -8.5% | -9.2% | -10.6% | -29.8% | +5.3% | -9.9% | -23.5% | -22.5% | -12.5% | -13.6% | |
| – | -60.5% | +27.2% | +47.1% | +75.3% | +88.8% | +52.3% | +33.6% | -12.7% | +36.1% | +31.8% | -74.8% | -17.0% | +101.0% | -20.6% | +56.8% | -26.1% | +87.1% | +54.7% | +14.5% | +38.1% | -22.8% | +117.5% | +15.0% | +1.8% | +160.0% | +1.8% | -1.7% | |
| – | -62.3% | +30.4% | +49.6% | +73.7% | +79.2% | -1.8% | +81.2% | -27.4% | +55.0% | -15.0% | -64.5% | -58.6% | +58.2% | +72.7% | +64.5% | -53.1% | +27.5% | +119.2% | +2.8% | -10.9% | +55.6% | +183.3% | +27.0% | +13.4% | +67.4% | +26.7% | -4.1% | |
| – | -65.2% | -29.0% | +47.3% | +84.3% | +42.6% | +652.0% | +15.8% | +6.0% | -69.1% | +792.6% | -100.0% | – | – | +1,888.4% | -24.8% | – | – | – | +38.9% | -97.1% | +5,752.5% | -88.6% | +34.4% | -11.6% | +1,566.5% | -3.4% | +16.7% | |
| – | -36.3% | +47.7% | +49.7% | +34.5% | +129.9% | -25.8% | +28.4% | -32.7% | +199.4% | -100.0% | +203,421,953.0% | -57.9% | -56.0% | +209.8% | -5.2% | +26.0% | +49.4% | +37.7% | +31.8% | +87.4% | -41.3% | -36.6% | +47.2% | -20.4% | +40.2% | +19.9% | -36.1% | |
| – | – | – | -4.2% | +125.8% | +84.6% | +1,354.6% | -32.8% | -73.7% | -86.7% | +9,906.4% | -100.0% | – | – | -100.0% | – | – | -51.1% | +66.2% | +29.1% | – | – | – | – | – | – | – | – | |
| – | – | +299.7% | +176.5% | +34.8% | +44.1% | -23.8% | -18.9% | -52.4% | +40.9% | -72.3% | -38.9% | +32.0% | +1.0% | -133.1% | – | +239.1% | -55.7% | +80.1% | +361.0% | -32.1% | +165.2% | +36.6% | +17.5% | -15.4% | -6.8% | -0.1% | +54.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.8% | +38.0% | +36.9% | +25.7% | +9.1% | +7.2% | +4.8% | +6.6% | +22.8% | +2.7% | +12.7% | +6.5% | +35.7% | +2.7% | +78.6% | +359.6% | +10.3% | +9.7% | +118.1% | +10.2% | +9.7% | +27.4% | +9.2% | +9.7% | +0.9% | +2.1% | -5.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.